Article Versions Notes

Pagotto S, Veronese A, Soranno A, Balatti V, Ramassone A, Guanciali-Franchi PE, Palka G, Innocenti I, Autore F, Rassenti LZ, et al. HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia. Cancers. 2019; 11(4):575. https://doi.org/10.3390/cancers11040575

Pagotto, Sara, Angelo Veronese, Alessandra Soranno, Veronica Balatti, Alice Ramassone, Paolo E. Guanciali-Franchi, Giandomenico Palka, Idanna Innocenti, Francesco Autore, Laura Z. Rassenti, and et al. 2019. "HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia" Cancers 11, no. 4: 575. https://doi.org/10.3390/cancers11040575

Pagotto, S., Veronese, A., Soranno, A., Balatti, V., Ramassone, A., Guanciali-Franchi, P. E., Palka, G., Innocenti, I., Autore, F., Rassenti, L. Z., Kipps, T. J., Mariani-Costantini, R., Laurenti, L., Croce, C. M., & Visone, R. (2019). HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia. Cancers, 11(4), 575. https://doi.org/10.3390/cancers11040575